ANTHRAX AS A BIOLOGICAL WEAPON: POSSIBILITIES OF APPLICATION DURING WAR
DOI:
https://doi.org/10.11603/1681-2727.2024.2.14614Keywords:
biological weapons, anthrax, genome editing, countermeasuresAbstract
SUMMARY. In the current war conditions, the temptation to use biological weapons by an aggressor, especially if it is possible to use them covertly under the guise of natural epidemics, is extremely great.
A detailed analysis of combat strains of the causative agent of anthrax – B. anthracis, features of epidemiology, pathogenesis, clinic, therapy and specific immunoprophylaxis caused by them is presented, which already allows us to take all possible measures and be fully prepared for the possible use of combat strains of B. antracis by the enemy.
In view of the threat of actual use of combat strains of B. antracis and/or other types of biological weapons, it is necessary to fully restore the destroyed sanitary and anti-epidemic service both in the civilian sector and in the structure of military and army units, as well as specialized army units for the prevention and control of results of the use of biological weapons as weapons of mass destruction.
References
Vonnegut, K. (2010). Cat’s cradle. M.: “AST”, 288 [in Russian].
Andreychyn, M. A., Kopcha, V. S. (2004). Biological weapons and bioterrorism. Zdorovya Ukrayiny – Health of Ukraine, 5(90), 40–41 [in Ukrainian].
Andreychyn, M. A., Kopcha, V. S. (2004). Medical problems of combating bioterrorism. Suchasni infektsiyi – Modern infections, 1, 94–108 [in Ukrainian].
Andreychyn, M. A., Kopcha, V. S. (2005). Bioterrorism: Medical countermeasures. Ternopil: Ukrmedknyha, 300 [in Ukrainian].
Andreychyn, M. A., Kopcha, V. S. (2011). Medical aspects of combating bioterrorism. SES profilaktychna medytsyna – SES preventive medicine, 2, 8–14 [in Ukrainian].
Darling, G., Noste, E. E., Chap, R. (2016). Future Biological and Chemical Weapons. Ciottone’s Disaster Medicine, 80, 489–498.
Nikolakakis, I., Michaleas, S. N., Panayiotakopoulos, G., Papaioannou, T. G., Karamanou, M., Michaleas, S., & Papaioannou, T. (2023). The History of Anthrax Weaponization in the Soviet Union. Cureus, 15(3).
Inglesby, T. V., O’Toole, T., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., ... & Working Group on Civilian Biodefense. (2002). Anthrax as a biological weapon, 2002: updated recommendations for management. Jama, 287(17), 2236-2252.
Vozianova, Zh. I. (2002). Infectious and parasitic diseases: In 3 volumes. K: Health, Volume 3 [in Russian].
Johari, M. R. (2002). Anthrax-biological threat in the 21st century. The Malaysian Journal of Medical Sciences: MJMS, 9(1), 1.
Kemper, M. J. (2012). Outbreak of hemolytic uremic syndrome caused by E. coli O104: H4 in Germany: a pediatric perspective. Pediatric Nephrology, 27, 161-164.
Bower, W. A., Schiffer, J., Atmar, R. L., Keitel, W. A., Friedlander, A. M., Liu, L., ... & Hendricks, K. (2019). Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices, 2019. MMWR Recommendations and Reports, 68(4), 1.
Wright, J. G., Quinn, C. P., Shadomy, S., Messonnier, N., & Centers for Disease Control and Prevention (CDC). (2010). Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm. Rep., 59(RR-6), 1-30.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 А. М. Бондаренко
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0
